Lluvido, Almera T.

HRN: 23-12-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFAZOLIN 1GM (VIAL)
05/30/2023
05/30/2023
IV
2g
En Route To OR
Stat Primary CS
Waiting Final Action 
05/30/2023
CEFUROXIME 500MG (TAB)
05/30/2023
06/05/2023
PO
500mg
BID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: